Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study

被引：128

作者：

Kusumoto, Shigeru ^{[1
]}

Tanaka, Yasuhito ^{[2
,3
]}

Suzuki, Ritsuro ^{[4
]}

Watanabe, Takashi ^{[5
]}

Nakata, Masanobu ^{[6
]}

Takasaki, Hirotaka ^{[7
]}

Fukushima, Noriyasu ^{[8
]}

Fukushima, Takuya ^{[9
]}

Moriuchi, Yukiyoshi ^{[10
]}

Itoh, Kuniaki ^{[11
]}

Nosaka, Kisato ^{[12
]}

Choi, Ilseung ^{[13
]}

Sawa, Masashi ^{[14
]}

Okamoto, Rumiko ^{[15
]}

Tsujimura, Hideki ^{[16
]}

Uchida, Toshiki ^{[17
]}

Suzuki, Sachiko ^{[18
]}

Okamoto, Masataka ^{[19
]}

Takahashi, Tsutomu ^{[20
]}

Sugiura, Isamu ^{[21
]}

Onishi, Yasushi ^{[22
]}

Kohri, Mika ^{[23
]}

Yoshida, Shinichiro ^{[24
]}

Sakai, Rika ^{[25
]}

Kojima, Minoru ^{[26
]}

Takahashi, Hiroyuki ^{[27
]}

Tomita, Akihiro ^{[28
]}

Maruyama, Dai ^{[5
]}

Atsuta, Yoshiko ^{[4
]}

Tanaka, Eiji ^{[29
]}

Suzuki, Takayo ^{[30
]}

Kinoshita, Tomohiro ^{[31
]}

Ogura, Michinori ^{[17
]}

Mizokami, Masashi ^{[32
]}

Ueda, Ryuzo ^{[33
]}

机构：

[1] Nagoya City Univ, Grad Sch Med Sci, Dept Hematol & Oncol, Nagoya, Aichi, Japan

[2] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan

[3] Nagoya City Univ, Grad Sch Med Sci, Liver Unit, Nagoya, Aichi, Japan

[4] Nagoya City Univ, Grad Sch Med Sci, Dept Hematopoiet Stem Cell Transplantat Data Mana, Nagoya, Aichi, Japan

[5] Natl Canc Ctr, Dept Hematol, Tokyo, Japan

[6] Sapporo Hokuyu Hosp, Dept Internal Med, Sapporo, Hokkaido, Japan

[7] Kanagawa Canc Ctr, Dept Med Oncol, Yokohama, Kanagawa 2410815, Japan

[8] Saga Univ, Fac Med, Dept Internal Med, Div Hematol, Saga, Japan

[9] Nagasaki Univ, Atom Bomb Dis Inst, Atom Bomb Dis & Hibakusha Med Unit, Dept Hematol, Nagasaki, Japan

[10] Sasebo City Gen Hosp, Dept Hematol, Sasebo, Japan

[11] Natl Canc Ctr Hosp East, Div Hematol & Oncol, Kashiwa, Chiba, Japan

[12] Kumamoto Univ, Sch Med, Dept Hematol & Infect Dis, Kumamoto 860, Japan

[13] Natl Hosp Org, Kyushu Canc Ctr, Div Hematol, Fukuoka, Japan

[14] Anjo Kosei Hosp, Dept Hematol & Oncol, Anjo, Aichi, Japan

[15] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Chemotherapy, Tokyo, Japan

[16] Chiba Canc Ctr, Div Hematol Oncol, Chiba, Japan

[17] Nagoya Daini Red Cross Hosp, Dept Hematol & Oncol, Nagoya, Aichi, Japan

[18] Natl Hosp Org, Hokkaido Canc Ctr, Dept Hematol, Sapporo, Hokkaido, Japan

[19] Fujita Hlth Univ, Sch Med, Dept Hematol & Med Oncol, Toyoake, Aichi 47011, Japan

[20] Shimane Univ Hosp, Dept Oncol Hematol, Izumo, Shimane, Japan

[21] Toyohashi Municipal Hosp, Div Hematol & Oncol, Toyohashi, Aichi, Japan

[22] Tohoku Univ Hosp, Dept Hematol & Rheumatol, Sendai, Miyagi, Japan

[23] Saitama Med Univ, Int Med Ctr, Dept Hematol, Hidaka, Japan

[24] Natl Hosp Org, Nagasaki Med Ctr, Dept Hematol, Ohmura, Japan

[25] Yokohama City Univ, Med Ctr, Dept Hematol, Yokohama, Kanagawa, Japan

[26] Tokai Univ, Sch Med, Dept Hematol & Oncol, Isehara, Kanagawa 25911, Japan

[27] Yokohama City Univ, Grad Sch Med, Dept Internal Med & Clin Immunol, Yokohama, Kanagawa, Japan

[28] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi 4648601, Japan

[29] Shinshu Univ, Sch Med, Dept Med, Matsumoto, Nagano 390, Japan

[30] Shiga Med Ctr Adults, Dept Hematol & Oncol, Moriyama, Japan

[31] Aichi Canc Ctr Hosp, Dept Hematol & Cell Therapy, Nagoya, Aichi 464, Japan

[32] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Ichikawa, Japan

[33] Aichi Med Univ, Sch Med, Dept Tumor Immunol, Nagoya, Aichi, Japan

来源：

CLINICAL INFECTIOUS DISEASES | 2015年 / 61卷 / 05期

关键词：

HBV DNA monitoring; HBV reactivation; resolved HBV infection; rituximab; preemptive antiviral therapy; RANDOMIZED CONTROLLED-TRIAL; CYTOTOXIC CHEMOTHERAPY; RECEIVING RITUXIMAB; MALIGNANT-LYMPHOMA; INFECTION; LAMIVUDINE; THERAPY; PATIENT; IMMUNOGENICITY; PROPHYLAXIS;

D O I：

10.1093/cid/civ344

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Background. There is no standard management of reactivation of hepatitis B virus (HBV) infection in HBV-resolved patients without hepatitis B surface antigen (HBsAg), but with antibodies against hepatitis B core antigen and/or antibodies against HBsAg (anti-HBs). Methods. We conducted a prospective observational study to evaluate the occurrence of HBV reactivation by serial monthly monitoring of HBV DNA and to establish preemptive therapy guided by this monitoring in B-cell non-Hodgkin lymphoma (B-NHL) treated with rituximab plus corticosteroid-containing chemotherapy (R-steroid-chemo). The primary endpoint was the incidence of HBV reactivation defined as quantifiable HBV DNA levels of >= 11 IU/mL. Results. With a median HBV DNA follow-up of 562 days, HBV reactivation was observed in 21 of the 269 analyzed patients. The incidence of HBV reactivation at 1.5 years was 8.3% (95% confidence interval, 5.5-12.4). No hepatitis due to HBV reactivation was observed in patients who received antiviral treatment when HBV DNA levels were between 11 and 432 IU/mL. An anti-HBs titer of <10 mIU/mL and detectable HBV DNA remaining below the level of quantification at baseline were independent risk factors for HBV reactivation (hazard ratio, 20.6 and 56.2, respectively; P < .001). Even in 6 patients with a rapid increase of HBV due to mutations, the monthly HBV DNA monitoring was effective at preventing HBV-related hepatitis. Conclusions. Monthly monitoring of HBV DNA is useful for preventing HBV reactivation-related hepatitis among B-NHL patients with resolved HBV infection following R-steroid-chemo (UMIN000001299).

引用

页码：719 / 729

页数：11

共 50 条

[41] Risk of hepatitis B virus reactivation during immunosuppressive treatment [J].

Kefeli, A. ;

Tutkaoglu, S. ;

Coskun, U. S. .

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (07) :2823-2831

[42] Rituximab increases the risk of hepatitis B virus reactivation in non-Hodgkin lymphoma patients who are hepatitis B surface antigen-positive or have resolved hepatitis B virus infection in a real-world setting: a retrospective study [J].

Tsai, Yu-Fen ;

Yang, Ching-, I ;

Du, Jeng-Shiun ;

Lin, Ming-Hui ;

Tang, Shih-Hao ;

Wang, Hui-Ching ;

Cho, Shih-Feng ;

Liu, Yi-Chang ;

Su, Yu-Chieh ;

Dai, Chia-Yen ;

Hsiao, Hui-Hua .

PEERJ, 2019, 7

[43] Reactivation of Hepatitis B Virus After Rituximab-Containing Treatment in Patients With CD20-Positive B-Cell Lymphoma [J].

Matsue, Kosei ;

Kimura, Shun-ichi ;

Takanashi, Yoko ;

Iwama, Kan-ichi ;

Fujiwara, Hideaki ;

Yamakura, Masayuki ;

Takeuchi, Masami .

CANCER, 2010, 116 (20) :4769-4776

[44] Immunological Analysis of a Patient with Hepatitis B Virus (HBV) Reactivation after Bone Marrow Transplantation [J].

Kowazaki, Yuka ;

Osawa, Yosuke ;

Imamura, Jun ;

Ohashi, Kazuteru ;

Sakamaki, Hisashi ;

Kimura, Kiminori .

INTERNAL MEDICINE, 2015, 54 (10) :1213-1217

[45] A Hepatitis B Virus Reactivation Case Potentially Triggered by the Onset of Diffuse Large B Cell Lymphoma [J].

Sato, Kentaro ;

Imamura, Hidemichi ;

Watahiki, Yu ;

Hazama, Hiromasa ;

Hashimoto, Takeaki ;

Mukae, Shinji ;

Ohhira, Hiromasa .

INTERNAL MEDICINE, 2023, 62 (11) :1611-1615

[46] Analysis of Clinical Characteristics and S Gene Mutation of Hepatitis B Virus (HBV) in Patients with Hepatitis B Surface Antigen RIA Negative and HBV DNA Positive [J].

Sohn, Yong-Hak ;

Oh, Heung-Bum ;

Ko, Sun-Young ;

Lim, Young-Suk ;

Kwon, Oh-Joong .

KOREAN JOURNAL OF LABORATORY MEDICINE, 2009, 29 (03) :224-230

[47] Screening for and management of hepatitis B virus reactivation in patients treated with anti-B-cell therapy [J].

Kusumoto, Shigeru ;

Tobinai, Kensei .

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2014, :576-583

[48] Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis [J].

Koo, Yu Xuan ;

Tay, Matthew ;

Teh, Yii Ean ;

Teng, David ;

Tan, Daniel S. W. ;

Tan, Iain B. H. ;

Tai, David W. M. ;

Quek, Richard ;

Tao, Miriam ;

Lim, Soon Thye .

ANNALS OF HEMATOLOGY, 2011, 90 (10) :1219-1223

[49] Maternal hepatitis B virus (HBV) DNA positivity and sexual intercourse are associated with HBV intrauterine transmission in China: A prospective case-control study [J].

Shao, Zhong-Jun ;

Xu, De-Zhong ;

Xu, Jian-Qiu ;

Li, Jing-Hua ;

Yan, Yong-Ping ;

Men, Ke ;

Wang, Xue-Ping ;

Zhang, Zhi-Ying ;

Jiang, Qin-Wu ;

Zhang, Lei .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (02) :165-170

[50] Hepatitis B Reactivation in Patients With Previous Hepatitis B Virus Exposure Undergoing Rituximab-Containing Chemotherapy for Lymphoma: A Prospective Study [J].

Seto, Wai-Kay ;

Chan, Thomas S. Y. ;

Hwang, Yu-Yan ;

Wong, Danny Ka-Ho ;

Fung, James ;

Liu, Kevin Sze-Hang ;

Gill, Harinder ;

Lam, Yuk-Fai ;

Lie, Albert K. W. ;

Lai, Ching-Lung ;

Kwong, Yok-Lam ;

Yuen, Man-Fung .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (33) :3736-+

← 1 2 3 4 5 →